| 1. Yan L, Müller CE.. (2004) Preparation, properties, reactions, and adenosine receptor affinities of sulfophenylxanthine nitrophenyl esters: toward the development of sulfonic acid prodrugs with peroral bioavailability., 47 (4): [PMID:14761205] [10.1021/jm0310030] |
| 2. Hamilton HW, Ortwine DF, Worth DF, Badger EW, Bristol JA, Bruns RF, Haleen SJ, Steffen RP.. (1985) Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application., 28 (8): [PMID:2991519] [10.1021/jm00146a016] |
| 3. Dooley MJ, Quinn RJ. (1992) An explanation of the substituent effect of 1,3,8-trisubstituted xanthines on adenosine A1/A2 affinity., 2 (10): [10.1016/S0960-894X(00)80213-9] |
| 4. Shamim MT, Ukena D, Padgett WL, Daly JW.. (1989) Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions., 32 (6): [PMID:2724296] [10.1021/jm00126a014] |
| 5. Erickson RH, Hiner RN, Feeney SW, Blake PR, Rzeszotarski WJ, Hicks RP, Costello DG, Abreu ME.. (1991) 1,3,8-trisubstituted xanthines. Effects of substitution pattern upon adenosine receptor A1/A2 affinity., 34 (4): [PMID:2016719] [10.1021/jm00108a029] |
| 6. Daly JW, Padgett WL, Shamim MT.. (1986) Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents., 29 (8): [PMID:3016270] [10.1021/jm00158a034] |
| 7. Grahner B, Winiwarter S, Lanzner W, Müller CE.. (1994) Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists., 37 (10): [PMID:8182711] [10.1021/jm00036a019] |
| 8. Jacobson KA, Kiriasis L, Barone S, Bradbury BJ, Kammula U, Campagne JM, Secunda S, Daly JW, Neumeyer JL, Pfleiderer W.. (1989) Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors., 32 (8): [PMID:2754711] [10.1021/jm00128a031] |
| 9. Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA.. (2002) Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions., 45 (11): [PMID:12014951] [10.1021/jm0104318] |
| 10. Jacobson KA, Ukena D, Padgett W, Daly JW, Kirk KL.. (1987) Xanthine functionalized congeners as potent ligands at A2-adenosine receptors., 30 (1): [PMID:3806597] [10.1021/jm00384a037] |
| 11. Jacobson KA, Shi D, Gallo-Rodriguez C, Manning M, Müller C, Daly JW, Neumeyer JL, Kiriasis L, Pfleiderer W.. (1993) Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors., 36 (18): [PMID:8410976] [10.1021/jm00070a007] |
| 12. Daly JW, Padgett W, Shamim MT, Butts-Lamb P, Waters J.. (1985) 1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors., 28 (4): [PMID:2984420] [10.1021/jm00382a018] |
| 13. Shamim MT, Ukena D, Padgett WL, Hong O, Daly JW.. (1988) 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors., 31 (3): [PMID:3346878] [10.1021/jm00398a020] |
| 14. van der Wenden EM, Ijzerman AP, Soudijn W.. (1992) A steric and electrostatic comparison of three models for the agonist/antagonist binding site on the adenosine A1 receptor., 35 (4): [PMID:1542091] [10.1021/jm00082a003] |
| 15. PubChem BioAssay data set, |
| 16. PubChem BioAssay data set, |
| 17. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 18. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 19. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 20. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
